Phastar Appoints Graham Clark as New Chief Executive Officer
10 August 2023 -- London, UK -- Phastar Sets Course for Further Growth with New CEO Appointment
Phastar, a global specialist biometrics Contract Research Organisation (CRO), today announced the appointment of Graham Clark as the new chief executive officer. Amid ambitious growth plans and organisational changes, Clark will succeed Andrew MacGarvey as CEO and further boost the paradigm shift in delivery of world-class data quality oversight. Having positioned the company for success, MacGarvey will assume the chief operating officer (COO) role, maintaining his Board position.
As former managing director with Phlexglobal, a global authority in Trial Master File (TMF) technology and services, Clark adds strong operational and commercial experience to the Phastar team. An accomplished leader with a proven track record in Operations, Strategy and Change management, he brings over 25 years’ experience in life sciences, financial and professional services organisations.
Speaking on behalf of the Phastar Board of Directors, Steve Kent (chair) said: “We are very pleased to welcome Graham to Phastar. Graham is known for building strong teams around a compelling vision, providing clear focus and results orientation and managing teams through transformational change. We are confident that Graham is very well-placed to take Phastar to the next level as global specialist biometrics CRO and further enhance the value we deliver to our customers, employees and life sciences industry as a whole.”
Kent continued: “The Board remains extremely appreciative of Andrew MacGarvey’s highly respected leadership over many years, which has built a strong organisation and solidified Phastar’s market-leading position. We are delighted that we will continue to benefit from his experience in an operational role as COO moving forward.”
“We all welcome Graham’s appointment at this juncture, with the company well poised for exciting growth,” said MacGarvey. “I look forward to working closely with him and the Leadership team to further transform and shape the future for our Phastar community.”
Commenting on his new CEO role, Clark said: “I am delighted with my appointment to lead Phastar, cementing our position as a world-leading, specialist biometric CRO. I believe we are uniquely placed to unlock the value of increasingly complex data and accelerate the development of promising new medicines. Phastar has enjoyed unprecedented growth underpinned by quality service and first-class delivery, earning its reputation of excellence within biopharma and medical device communities. I am looking forward to working with our talented team to continue delivering the highest quality data standards. These are exciting times to join Phastar and build on a shared legacy, and I’m excited to spearhead this new wave of growth.”
About Phastar Phastar is an award winning, global, specialist biometrics contract research organisation offering leading data management, data science, statistical consulting and clinical trial reporting services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements, and preferred partnerships. Phastar currently has 14 offices worldwide with plans to open additional locations in the future to serve prospective and existing clients. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilises internal processes designed to guarantee optimal quality, inspired by 4,000 years accumulated technical experience across the company.
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.